Error: Could not add to watchlist. X
+ Watchlist

Poniard Pharmaceuticals Inc

NX1B:GR
Munich
Price not available for NX1B:GR
EUR
Volume
0
Previous Close
0.06
52Wk Range
0.05 - 0.16
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Previous Close
0.06
52Wk Range
0.05 - 0.16
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (EUR)
-
Shares Outstanding (m)
1.499
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+1.05%
% Price Change
+1.26%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Poniard Pharmaceuticals, Inc. develops drugs used to treat cancer.
Address
7000 Shoreline Court
Suite 270
S San Francisco, CA 94080
United States
Phone
1-650-583-3774
  • Cheni Kwok
    VP:Business Development
  • Linda T Findlay
    VP:Human Resources
Show More